Abbott P/E Ratio
Current P/E Ratio
34.01
High Valuation
Very High - High growth expectations or significantly overvalued
Abbott P/E ratio. Abbott (ABBOTINDIA) P/E ratio is 34.01 (High), EPS (TTM) ₹730.36, current price ₹25360.00 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Abbott share price chart.
Current Valuation Metrics
P/E Ratio
34.01
Current Price
₹25360.00
EPS (TTM)
₹730.36
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
54.93
Sector Median
31.69
Sector Rank
#11 of 200
Sector Percentile
5.5%
ABBOTINDIA P/E Ratio — Valuation Signal & Historical Context
Abbott P/E 34.01 — signal: Overvalued. Also explore ABBOTINDIA price trends to track price trends across different timeframes.
- Stock appears overvalued with PE of 34.01, suggesting caution for new investments
- Trading at discount to sector average PE of 54.93
ABBOTINDIA vs Healthcare Peers — P/E Ratio Comparison
Abbott P/E 34.01 vs Healthcare average 54.93, median 31.69 — range 2.02–722.21.
Sector Average
54.93
Sector Median
31.69
Lowest P/E
2.02
Highest P/E
722.21
Companies
200
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.02 | ₹60 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.33 | ₹55 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.86 | ₹6,006 | Low |
| Dipna Pharmachem | DPL | 3.97 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 5.05 | ₹65 | Low |
| Royal Sense | ROYAL | 5.39 | ₹40 | Low |
| Kabra Drugs | KABRADG | 5.47 | ₹41 | Low |
| GKB Ophthalmics | GKB | 5.85 | ₹32 | Low |
| Colinz Laboratories | COLINZ | 6.31 | ₹18 | Low |